Transforming growth factor-β (TGF-β) is one of the immunosuppressive targets found on the surface of tEVs: in patients suffering from acute myeloid leukemia and breast cancer; it is involved in the suppression of natural killer (NK) cell function and T-cell proliferation [105]. The gene discussed is TGFB1; the disease is breast carcinoma.